-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Tamoxifen is a selective estrogen receptor modulator (SERM) that is widely used in the treatment of breast cancer.
The chemical industry plays a crucial role in the synthesis of tamoxifen, with several different synthetic routes being used to produce this important medication.
The first synthetic route for tamoxifen was developed in the early 1960s by researchers at the Sterling Drug Company.
This route involved the synthesis of tamoxifen from the precursor compound 4-hydroxy-tamoxifen, which was obtained from the natural product estrogen equilin.
The synthesis of tamoxifen from 4-hydroxy-tamoxifen involved a series of chemical reactions, including a nucleophilic substitution reaction, a lactamization reaction, and a reduction reaction.
In the 1970s, a second synthetic route for tamoxifen was developed, which involved the synthesis of tamoxifen from the natural product compound triptorelin.
This route involved a series of chemical reactions, including a reduction reaction, a condensation reaction, and a halogenation reaction.
In the 1980s, a third synthetic route for tamoxifen was developed, which involved the synthesis of tamoxifen from the natural product compound genistein.
This route involved a series of chemical reactions, including a hydrolysis reaction, a condensation reaction, and a halogenation reaction.
In the 1990s, a fourth synthetic route for tamoxifen was developed, which involved the synthesis of tamoxifen from the natural product compound citrolelin.
This route involved a series of chemical reactions, including a reduction reaction, a condensation reaction, and a halogenation reaction.
In the 21st century, many other synthetic routes for tamoxifen have been developed, including routes that use synthetic precursors such as 4-hydroxy-tamoxifen, as well as routes that use new and innovative chemical reactions.
One example of a modern synthetic route for tamoxifen is the route that uses 4-hydroxy-tamoxifen as the starting material, which involves a series of chemical reactions, including a nitroalkane reaction, a reduction reaction, and a halogenation reaction.
Overall, the synthetic routes for tamoxifen have undergone significant changes over the years, with new and innovative routes being developed to improve the efficiency and cost-effectiveness of tamoxifen production.
These routes have enabled the large-scale production of tamoxifen, which is essential for its use in the treatment of breast cancer.
